Authors:
VANDENBENT MJ
SCHELLENS JHM
VECHT CJ
SMIT PAES
LOOSVELD OJL
MA J
TIJSSEN CC
JANSEN RLH
KROS JM
VERWEIJ J
Citation: Mj. Vandenbent et al., PHASE-II STUDY ON CISPLATIN AND IFOSFAMIDE IN RECURRENT HIGH-GRADE GLIOMAS, European journal of cancer, 34(10), 1998, pp. 1570-1574
Citation: Lc. Pronk et al., CORTICOSTEROID CO-MEDICATION DOES NOT REDUCE THE INCIDENCE AND SEVERITY OF NEUROTOXICITY INDUCED BY DOCETAXEL, Anti-cancer drugs, 9(9), 1998, pp. 759-764
Authors:
STRAATHOF CSM
VANDENBENT MJ
MA J
SCHMITZ PIM
KROS JM
STOTER G
VECHT CJ
SCHELLENS JHM
Citation: Csm. Straathof et al., THE EFFECT OF DEXAMETHASONE ON THE UPTAKE OF CISPLATIN IN 9L GLIOMA AND THE AREA OF BRAIN AROUND TUMOR, Journal of neuro-oncology, 37(1), 1998, pp. 1-8
Authors:
VANDENBENT MJ
KROS JM
HEIMANS JJ
PRONK LC
VANGROENINGEN CJ
KROUWER HGJ
TAPHOORN MJB
ZONNENBERG BA
TIJSSEN CC
TWIJNSTRA A
PUNT CJA
BOOGERD W
Citation: Mj. Vandenbent et al., RESPONSE RATE AND PROGNOSTIC FACTORS OF RECURRENT OLIGODENDROGLIOMA TREATED WITH PROCARBAZINE, CCNU, AND VINCRISTINE CHEMOTHERAPY, Neurology, 51(4), 1998, pp. 1140-1145
Authors:
LUIDER TM
SMITT PAES
VANDENBENT MJ
VECHT CJ
KROS JM
Citation: Tm. Luider et al., CHARACTERIZATION OF ASTROCYTOMA AND OLIGODENDROGLIOMA SPECIFIC PROTEINS WITH 2-DIMENSIONAL ELECTROPHORESIS, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 15-15
Authors:
HILKENS PHE
VERWEIJ J
VECHT CJ
STOTER G
VANDENBENT MJ
Citation: Phe. Hilkens et al., CLINICAL CHARACTERISTICS OF SEVERE PERIPHERAL NEUROPATHY INDUCED BY DOCETAXEL (TAXOTERE), Annals of oncology, 8(2), 1997, pp. 187-190
Authors:
SIJENS PE
VANDENBENT MJ
NOWAK PJCM
VANDIJK P
OUDKERK M
Citation: Pe. Sijens et al., H-1 CHEMICAL-SHIFT IMAGING REVEALS LOSS OF BRAIN-TUMOR CHOLINE SIGNALAFTER ADMINISTRATION OF GD-CONTRAST, Magnetic resonance in medicine, 37(2), 1997, pp. 222-225
Authors:
PRONK LC
SCHELLENS JHM
PLANTING AST
VANDENBENT MJ
HILKENS PHE
VANDERBURG MEL
DEBOERDENNERT M
MA J
BLANC C
HARTEVELD M
BRUNO R
STOTER G
VERWEIJ J
Citation: Lc. Pronk et al., PHASE-I AND PHARMACOLOGICAL STUDY OF DOCETAXEL AND CISPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS, Journal of clinical oncology, 15(3), 1997, pp. 1071-1079
Citation: Mj. Vandenbent et al., PROGRESSION OF PACLITAXEL-INDUCED NEUROPATHY FOLLOWING DISCONTINUATION OF TREATMENT, Muscle & nerve, 20(6), 1997, pp. 750-752
Citation: Pe. Sijens et al., P-31 CHEMICAL-SHIFT IMAGING OF METASTATIC TUMORS LOCATED IN THE SPINEREGION, Investigative radiology, 32(6), 1997, pp. 344-350
Citation: Phe. Hilkens et al., PERIPHERAL NEUROPATHY INDUCED BY COMBINATION CHEMOTHERAPY OF DOCETAXEL AND CISPLATIN, British Journal of Cancer, 75(3), 1997, pp. 417-422
Authors:
VANDENBENT MJ
OOSTING J
WOUDA EJ
VANACKER REH
ANSINK BJJ
BRAAKMAN R
Citation: Mj. Vandenbent et al., ANTERIOR CERVICAL DISKECTOMY WITH OR WITHOUT FUSION WITH ACRYLATE - ARANDOMIZED TRIAL, Spine (Philadelphia, Pa. 1976), 21(7), 1996, pp. 834-839
Authors:
SIJENS PE
VANDENBENT MJ
VANDIJK P
OUDKERK M
Citation: Pe. Sijens et al., CHEMICAL-SHIFT IMAGING REVEALS LOSS OF BRAIN-TUMOR CHOLINE SIGNAL AFTER ADMINISTRATION OF A GADOLINIUM CONTRAST AGENT, Radiology, 201, 1996, pp. 11-11
Authors:
VANDENBENT MJ
KROS JM
SCHELLENS JHM
KROUWER HGJ
ZONNEBERG BA
HEIMANS JJ
VONGROENINGEN CJ
BOOGERD W
TIJSSEN CC
TWIJNSTRA A
Citation: Mj. Vandenbent et al., PCV-CHEMOTHERAPY IN RECURRENT OLIGODENDROGLIOMA - FACTORS OF PROGNOSTIC-SIGNIFICANCE, Neurology, 46(2), 1996, pp. 2038-2038
Authors:
PLANTING AST
VANDERBURG MEL
VANDENBENT MJ
DEBOERDENNERT M
STOTER G
VERWEIJ J
Citation: Ast. Planting et al., PHASE-II STUDY OF A SHORT-COURSE OF WEEKLY HIGH-DOSE CISPLATIN COMBINED WITH LONG-TERM ORAL ETOPOSIDE IN METASTATIC COLORECTAL-CANCER, British Journal of Cancer, 73(10), 1996, pp. 1265-1267
Citation: Phe. Hilkens et al., NEUROTOXICITY IS NOT ENHANCED BY INCREASED DOSE INTENSITIES OF CISPLATIN ADMINISTRATION, European journal of cancer, 31A(5), 1995, pp. 678-681
Authors:
PLANTING AST
VANDERBURG MEL
GOEY SH
SCHELLENS JHM
VANDENBENT MJ
DEBOERDENNERT M
STOTER G
VERWEIJ J
Citation: Ast. Planting et al., PHASE-II STUDY OF A SHORT-COURSE OF WEEKLY HIGH-DOSE CISPLATIN COMBINED WITH LONG-TERM ORAL ETOPOSIDE IN PLEURAL MESOTHELIOMA, Annals of oncology, 6(6), 1995, pp. 613-615
Authors:
MARKUSSE HM
HILKENS PHE
VANDENBENT MJ
VECHT CJ
Citation: Hm. Markusse et al., NORMAL-PRESSURE HYDROCEPHALUS ASSOCIATED WITH RHEUMATOID-ARTHRITIS RESPONDING TO PREDNISONE, Journal of rheumatology, 22(2), 1995, pp. 342-343
Citation: Phe. Hilkens et al., EFFECT OF AN ACTH(4-9) ANALOG ON CISPLATIN NEUROPATHY OF LONGSTANDINGDURATION - A PHASE-II STUDY, Clinical neurology and neurosurgery, 97(2), 1995, pp. 139-141